Physician

Nephrology

Dr. Nasimul Ahsan works in the field of Nephrology. He attended University of Texas Southwestern Medical School. Nasimul Ahsan is a published MD. He has 45 publications published. The most current publication "Pyrazinoylguanidine in end-stage renal disease: a prospective, placebo-controlled pilot study." Dr. Nasimul Ahsan accepts all Medicare patients.

Publications

---

• Pyrazinoylguanidine in end-stage renal Disease: a prospective, placebo-controlled pilot study.
• Acute renal failure following immunoglobulin therapy.
• Intravenous infusion of total dose iron is superior to oral iron in treatment of anemia in peritoneal dialysis patients: a single center comparative study.
• Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation.
• Immunohistochemical study of actin binding protein (p55) in the human Kidney.
• Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy.
• Gastrointestinal tuberculosis in Renal transplantation: a case report and review.
• Induction immunotherapy with IL-2Ra monoclonal antibody in Kidney transplantation.
• Laparoscopic-assisted Renal biopsy: an alternative to open approach.
• A comparative study of 500 mg BID and 250 mg BID of prophylactic oral ganciclovir in post-Kidney transplant "CMV at risk" recipients.
• Heat shock protein 47 in Renal scarring.
• Expression of angiotensin II type I receptor on erythroid progenitors of patients with post transplant erythrocytosis.
• Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidne...
• Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadave...
• Effect of use of vasopressors in organ donors on immediate function of Renal allografts.
• Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-Kidney transplant patients.
• Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation.
• Oral ganciclovir in the prevention of cytomegalovirus infection in postKidney transplant "CMV at risk" recipients: a controlled, comparative study of two regimens (750...
• Recurrent type I membranoproliferative glomerulonephritis after renal transplantation and protective role of cyclosporine in Acute crescentic transformation.
• Peloisis hepatis due to Bartonella henselae in transplantation: a hemato-hepato-Renal syndrome.
• Adverse effect of donor vasopressor support on immediate and one-year Kidney allograft function.
• Lipid formulations of polyene antifungal drugs and attenuation of associated nephrotoxicity.
• Prednisone withdrawal in Kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group.
• Successful reversal of Acute vascular rejection in a renal allograft with combined mycophenolate mofetil and tacrolimus as primary immunotherapy.
• New strategies using 'low-dose' mycophenolate mofetil to reduce Acute rejection in patients following kidney transplantation.
• Tacrolimus/"low-dose" mycophenolate mofetil versus microemulsion cyclosporine/"low-dose" mycophenolate mofetil after Kidney transplantation--1-year follow-up of a pros...
• Continued influence of preoperative Renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?
• Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy.
• Antibody immunosuppressive therapy in solid organ transplant: Part II.
• Antibody immunosuppressive therapy in solid-organ transplant: Part I.
• Excellent Renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
• Steroid avoidance: is it ready for prime time?
• Larva currens in a patient scheduled for Renal transplant.
• HepatoRenal syndrome: pathophysiology and management.
• The long-term management of pancreas transplantation.
• Pharmacotherapeutic options for the management of human polyomaviruses.
• Polyomaviruses and human Diseases.
• How can the poor outcomes for diabetic dialysis patients be improved?
• Pathogenesis and molecular mechanisms of Chronic allograft nephropathy.
• Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric Kidney transplantation: results at t...
• Hepatobiliary diseases after Kidney transplantation unrelated to classic hepatitis virus.
• Limited dose monoclonal IL-2R antibody induction protocol after primary Kidney transplantation.
• Role of apoptosis in fibrogenesis.
• Dialysis access failure: an indication for immediate Kidney transplantation.

Schools

---

• Chittagong Med College

• Eastern Va

• Eastern Va Grad School Med

• Penn State University

• University MD Hospital

• Ut Sw Med School

Procedures Preformed

---

• Hemodialysis

Conditions Treated

---

• Acidosis
• Acute Kidney Failure
• Alkalosis
• Chronic Kidney Diseases
• View All

Doctors Specialties

---

• Nephrology

Accepted Insurances

---

Education

---

• University of Texas Southwestern Medical School
• Eastern Virginia Medical School
• Penn State University
• University of Maryland
• Chittagong Medical College

Hospital

---

• UF Health Shands Hospital

Drug Facts

---

NPI NUMBER		1770572364
NPPES Provider LastName		AHSAN
NPPES Provider FirstName		NASIMUL
NPPES Provider ZIPCode		322241865
NPPES Provider State		FL
Specialty Description		Internal Medicine
Total Claim Count		39.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1770572364
Last Name Of The Provider	AHSAN
First Name Of The Provider	NASIMUL
View All

Similar Doctors

---

	Dr. Peter M. Fitzpatrick, MD This Doctor is OpenDoctor Recommended.
	Dr. James B. Smart Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. James D. Baker III, MD This Doctor is OpenDoctor Recommended.
	Dr. Ivan E. Porter Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Charles W. Heilig, MD This Doctor is OpenDoctor Recommended.
	Dr. Ira Harmon, MD
	Dr. Leighton R. James, MD This Doctor is OpenDoctor Recommended.
	Dr. Reuben K. Maggard, MD This Doctor is OpenDoctor Recommended.
	Dr. Suzanne M. Brulte, MD This Doctor is OpenDoctor Recommended.
	Dr. Muhammad A. Salahuddin, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog